Armis Advisers’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.21M Buy
8,821
+1,631
+23% +$230K 0.1% 147
2026
Q2
$1.03M Buy
7,190
+342
+5% +$62K 0.09% 165
2026
Q1
$1.3M Buy
6,848
+428
+7% +$69.6K 0.13% 131
2025
Q4
$961K Sell
6,420
-1,707
-21% -$406K 0.11% 146
2025
Q3
$2.13M Buy
8,127
+3,398
+72% +$865K 0.19% 78
2025
Q2
$1.07M Buy
4,729
+995
+27% +$161K 0.08% 179
2025
Q1
$524K Buy
3,734
+958
+35% +$156K 0.05% 243
2024
Q4
$463K Buy
+2,776
New +$493K 0.06% 196

Other funds holding ORCL

Armis Advisers's ORCL Position: Q3 2026 in Review

Armis Advisers increased its Oracle (ORCL) stake by 23% in Q3 2026, buying an estimated $230K and bringing the position to 8,821 shares worth $1.21M. The position accounts for 0.1% of the portfolio, ranked #147.

Armis Advisers first reported a position in ORCL in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.13M in Q3 2025. 784 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • Armis Advisers held 8,821 shares of Oracle worth $1.21M as of Q3 2026.
  • Armis Advisers bought 1,631 Oracle shares in Q3 2026, an estimated $230K.
  • Oracle made up 0.1% of Armis Advisers's portfolio in Q3 2026, its #147 holding.
  • Armis Advisers first reported a position in Oracle in Q4 2024 and has held it in 8 quarters since.
  • Armis Advisers's Oracle position peaked at $2.13M in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.